NCT07724587

Brief Summary

Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD). Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG). All groups received standard dialysis, health education, and dietary guidance. The SG received pre-dialysis PRT, while the IG added mindfulness meditation during dialysis. Efficacy and safety were evaluated at baseline and after 12 weeks. Ultrasound assessments of muscle mass were conducted at baseline, week 4, week 8, and week 12.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 1, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 24, 2026

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

April 22, 2026

Last Update Submit

July 20, 2026

Conditions

Outcome Measures

Primary Outcomes (8)

  • Change in 30-second Chair Stand Test (CS30)

    The range of the test result is 0-30 repetitions. Higher values indicate better lower limb muscle strength and physical function. The change value before and after 12-week intervention is the evaluation index

    12 weeks

  • Change in Handgrip Strength

    The unit of handgrip strength is kg. Higher values indicate improved upper limb muscle strength. The change value before and after 12-week intervention is the evaluation index

    12 weeks

  • Change in 6-Minute Walking Test (6MWT)

    The unit of walking distance is meters. Longer walking distance indicates better exercise tolerance and physical endurance. The change value before and after 12-week intervention is the evaluation index.

    12 weeks

  • Change in Stair Climbing Test

    The unit of test result is seconds. Shorter completion time indicates improved lower limb motor function. The change value before and after 12-week intervention is the evaluation index.

    12 weeks

  • Change in 10-Time Sit-to-Stand Test (TT10SU)

    The unit of test result is seconds. Shorter completion time indicates better lower limb muscle function. The change value before and after 12-week intervention is the evaluation index.

    12 weeks

  • Change in Timed Up and Go Test (TUGT)

    The unit of test result is seconds. Shorter completion time indicates better balance and mobility function. The change value before and after 12-week intervention is the evaluation index.

    12 weeks

  • Change in skeletal muscle thickness measured by ultrasound

    The unit of skeletal muscle thickness is cm. Greater muscle thickness indicates improved muscle mass. The change value before and after 12-week intervention is the evaluation index.

    4 weeks

  • Change in quality of life assessed by standardized scale

    Higher scores of the standardized quality of life scale represent improved quality of life and physical performance. The change value before and after 12-week intervention is the evaluation index.

    12 weeks

Study Arms (3)

control group (CG)

OTHER

Received routine hemodialysis treatment

Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.

sports group (SG)

ACTIVE COMPARATOR

Received pre-dialysis resistance training in addition to routine treatment.

Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.

intervention group (IG)

EXPERIMENTAL

Received mindfulness meditation training during dialysis in addition to exercise therapy.

Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.

Interventions

The SG received pre-dialysis progressive resistance training (PRT), while the IG added mindfulness meditation during dialysis.

control group (CG)intervention group (IG)sports group (SG)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet the updated Asian diagnostic criteria for sarcopenia
  • Stable vital signs and general physical condition
  • Willing and able to cooperate with supervised exercise training
  • Regular hemodialysis 3 times per week for at least 3 months

You may not qualify if:

  • Acute cardiovascular or cerebrovascular events within the previous 3 months
  • Cognitive dysfunction affecting study cooperation and exercise completion
  • Severe osteoarticular or limb movement disorders preventing standardized exercise training
  • Active systemic infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yongyao Wu

Ningbo, 315100, China

RECRUITING

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • yongyao wu

    Department of Nephrology, Ningbo Medical Center Li Huili Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2026

First Posted

July 24, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 24, 2026

Record last verified: 2025-09

Locations